Published in Law and Health Weekly, December 31st, 2005
A 2-year fellowship award from the Japan Society for the Promotion of Science supports Nakada's research at TGen, which focuses on searching for new therapeutic targets on primary brain tumors called gliomas. He has made fundamental discoveries on the role of a family of genes called ephrins, which control processes in the brain during normal development, such as how neurons...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly